Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts

Urologic Oncology: Seminars and Original Investigations

Volumn 25, Issue 4, 2007, Pages 291-297

  Malaeb, Bahaa S ^a   Rashid, Hani H ^a   Lotan, Yair ^b   Khoddami, Seyyed M ^b   Shariat, Shahrokh F ^b   Sagalowsky, Arthur I ^b   McConnell, John D ^b   Roehrborn, Claus G ^b   Koeneman, Kenneth S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Biochemical recurrence; Life expectancy; Prostate cancer; Radical retropubic prostatectomy; Watchful waiting

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BIOCHEMISTRY; BIOPSY; CANCER GROWTH; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEASIBILITY STUDY; GLEASON SCORE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RADICAL RETROPUBIC PROSTATECTOMY; SEMINAL VESICLE; SURVIVAL TIME; TIME SERIES ANALYSIS;

ADENOCARCINOMA; AGE DISTRIBUTION; AGED; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 34447108736     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2006.08.001     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention (CDC). Trends in aging-United States and worldwide. MMWR Morb Mortal Wkly Rep 52 (2003) 101-104
2. Krahn M.D., Bremner K.E., Asaria J., et al. The ten-year rule revisited: Accuracy of clinicians' estimates of life expectancy in patients with localized prostate cancer. Urology 60 (2002) 258-263
3. Johansson J.E., Andren O., Andersson S.O., et al. Natural history of early, localized prostate cancer. JAMA 291 (2004) 2713-2719
4. Kupelian P.A., Potters L., Khuntia D., et al. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 58 (2004) 25-33
5. Jo Y., Junichi H., Tomohiro F., et al. Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: Effects on health-related quality of life. BJU Int 96 (2005) 43-47
6. Khoddami S.M., Shariat S.F., Lotan Y., et al. Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy. BJU Int 94 (2004) 42-46
7. Lotan Y., Shariat S.F., Khoddami S.M., et al. The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy. J Urol 171 (2004) 2209-2214
8. Shariat S.F., Khoddami S.M., Saboorian H., et al. Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy. J Urol 171 (2004) 1122-1127
9. Henson D.E., Hutter R.V., Farrow G., A publication of the Cancer Committee, and College of American Pathologists. Practice protocol for the examination of specimens removed from patients with carcinoma of the prostate gland. Task Force on the Examination of Specimens Removed From Patients With Prostate Cancer. Arch Pathol Lab Med 118 (1994) 779-783
10. Kattan M.W., Wheeler T.M., and Scardino P.T. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 17 (1999) 1499-1507
11. Stamey T.A., Yemoto C.M., McNeal J.E., et al. Prostate cancer is highly predictable: A prognostic equation based on all morphological variables in radical prostatectomy specimens. J Urol 163 (2000) 1155-1160
12. Bauer J.J., Connelly R.R., Sesterhenn I.A., et al. Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomy. Cancer 79 (1997) 952-962
13. Alibhai S.M., Naglie G., Nam R., et al. Do older men benefit from curative therapy of localized prostate cancer?. J Clin Oncol 21 (2003) 3318-3327
14. Koch M.O., Miller D.A., Butler R., et al. Are we selecting the right patients for treatment of localized prostate cancer?. Results of an actuarial analysis. Urology 51 (1998) 197-202
15. Alibhai S.M., Krahn M.D., Cohen M.M., et al. Is there age bias in the treatment of localized prostate carcinoma. Cancer 100 (2004) 72-81
16. Dahm P., Silverstein A.D., Weizer A.Z., et al. When to diagnose and how to treat prostate cancer in the 'not too fit' elderly. Crit Rev Oncol Hematol 48 (2003) 123-131
17. Schwartz K.L., Alibhai S.M., Tomlinson G., et al. Continued undertreatment of older men with localized prostate cancer. Urology 62 (2003) 860-865
18. Albertsen P.C., Hanley J.A., Gleason D.F., et al. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 280 (1998) 975-980
19. Lu-Yao G.L., Albertsen P., Warren J., et al. Effect of age and surgical approach on complications and short-term mortality after radical prostatectomy-A population-based study. Urology 54 (1999) 301-307
20. Stanford J.L., Feng Z., Hamilton A.S., et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study. JAMA 283 (2000) 354-360
21. Bill-Axelson A., Holmberg L., Ruutu M., et al. Scandinavian Prostate Cancer Group Study No. 4. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352 (2005) 1977-1984
22. Freedland S.J., Presti Jr. J.C., Kane C.J., et al. Do younger men have better biochemical outcomes after radical prostatectomy?. Urology 63 (2004) 518-522
23. Khan M.A., Han M., Partin A.W., et al. Long term cancer control of radical prostatectomy in men younger than 50 years of age: Update 2003. Urology 62 (2003) 86-91
24. Smith C.V., Bauer J.J., Connelly R.R., et al. Prostate cancer in men age 50 years or younger: A review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database. J Urol 164 (2000) 1964-1967
25. Tewari A., Srivasatava A., Menon M., et al. A prospective comparison of radical retropubic and robot-assisted prostatectomy: Experience in one institution. BJU Int 92 (2003) 205-210